Disclosure Mike Kirby has received funding for research, conference attendance, lecturing and advice from the pharmaceutical industry including, Pfizer, MSD, GSK, Astellas, Bayer, Lilly and Takeda.
Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis
Article first published online: 25 APR 2013
© 2013 John Wiley & Sons Ltd
International Journal of Clinical Practice
Volume 67, Issue 7, pages 606–618, July 2013
How to Cite
Kirby, M., Chapple, C., Jackson, G., Eardley, I., Edwards, D., Hackett, G., Ralph, D., Rees, J., Speakman, M., Spinks, J. and Wylie, K. (2013), Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis. International Journal of Clinical Practice, 67: 606–618. doi: 10.1111/ijcp.12176
Chris Chapple has worked as a consultant to American Medical Systems and Lilly, as a consultant and researcher to ONO, as a consultant, researcher and speaker for Allergan, Astellas, Pfizer and Recordati.
Graham Jackson has advised Lilly, Pfizer and Bayer, and talked at sponsored educational meetings.
Ian Eardley has worked as a consultant and speaker for Lilly, Bayer, Pfizer and Allergan.
David Edwards has received funding for research, lecturing, advisory board and conference attendance from the pharmaceutical industry including Bayer, GSK, Lilly, Pfizer, ProStakan and Owen Mumford.
Geoff Hackett is an occasional speaker and advisory board member for Lilly and Bayer.
Jon Rees has worked as a consultant to Lilly, GSK and Pfizer, and has received speaker funding from GSK & Lilly.
David Ralph has worked as a consultant to Lilly, Axillium, Coloplast and American Medical Systems. Mark Speakman has received research funding from Allergan, Astellas, GSK and Genprobe. He has been a lecturer for Astellas, GSK, Lilly and Genprobe.
Julian Spinks has worked as a consultant to Pfizer, GSK, Astellas Orion and Boehringer Ingelheim, and received speaker fees from Pfizer and Astellas.
Kevan Wylie has no conflicts of interest.
Consensus statement: Evidence suggests a strong link between erectile dysfunction and lower urinary tract symptoms in men that is independent of age. Co-diagnosis of these conditions is therefore important.
Linked Comment: Rosenberg et al. Int J Clin Pract 2013; 67: 599–600.
- Issue published online: 13 JUN 2013
- Article first published online: 25 APR 2013
- Manuscript Accepted: 22 MAR 2013
- Manuscript Received: 10 DEC 2012
This article has been cited by:
- 1Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study, The Journal of Sexual Medicine, 2016,, , , , , , , , , , , , , , , , ,
- 2In Search for a Common Pathway for Health Issues in Men - the Sign of a Holmesian Deduction, Asian Pacific Journal of Cancer Prevention, 2016, 17, 1, 1, , , , ,
- 3Prevalence and risk factors for erectile dysfunction and lower urinary tract symptoms in Russian Federation men: analysis from a national population-based multicenter study, International Journal of Impotence Research, 2016, 28, 2, 74, , , , , , , , , ,
- 8Patient characteristics and treatment patterns for patients with benign prostatic hyperplasia, erectile dysfunction or co-occurring benign prostatic hyperplasia and erectile dysfunction in general practices in the UK: a retrospective observational study, International Journal of Clinical Practice, 2015, 69, 8, , , , , , , , ,
- 9Phosphodiesterase type 5 inhibitors for treating erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia: A comprehensive review, Arab Journal of Urology, 2015, 13, 3, 155, , ,
- 10Predicting erectile dysfunction in sexually active patients seeking prostate health screening: proposal for a multivariable risk stratification, International Journal of Impotence Research, 2015, 27, 6, 201, , , , , , , , , ,
- 11Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population, BMC Urology, 2015, 15, 1, , , , , , , , , ,
- 13The correlation between lower urinary tract symptoms (LUTS) and erectile dysfunction (ED): results from a survey in males from Mexico City (MexiLUTS), World Journal of Urology, 2015,, , , , , , , , , ,
- 14Men's Health Index: A Pragmatic Approach to Stratifying and Optimizing Men's Health, Korean Journal of Urology, 2014, 55, 11, 710, , , , , ,
- 17Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil, The World Journal of Men's Health, 2013, 31, 3, 193, , , , ,